medigraphic.com
Antes Revista del Instituto Nacional de Enfermedades Respiratorias

 Ver anteriores al 2010

2014, Número 4

Neumol Cir Torax 2014; 73 (4)


Derrame pleural refractario en el lupus eritematoso sistémico del niño. Reporte de caso

Sancho-Hernández R, Gutiérrez-Morales G, Cuevas-Schacht FJ

Idioma: Español
Referencias bibliográficas: 40
Paginas: 236-242
Archivo PDF: 289.18 Kb.


RESUMEN

Presentamos el caso clínico de un adolescente de 14 años de edad con derrame pleural masivo y bilateral en el curso de un lupus eritematoso sistémico y refractario al tratamiento esteroideo e inmunosupresor. Se describe la revisión de la literatura en la edad pediátrica y el análisis de las opciones terapéuticas actuales.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bouros D, Pneumatikos I, Tzouvelekis A. Pleural involvement in systemic autoimmune disorders. Respiration 2008;75(4):361-371. doi: 10.1159/000119051.

  2. Bouros D, Panagou P, Papandreou L, Kottakis I, Tegos C. Massive bilateral pleural effusion as the only first presentation of systemic lupus erythematosus. Respiration 1992;59(3):173-175.

  3. Pohlgeers AP, Eid NS, Schikler KN, Shearer LT. Systemic lupus erythematosus: pulmonary presentation in childhood. South Med J 1990;83(6):712-714.

  4. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981;71(5):791-798.

  5. Quismorio FP Jr. Clinical and pathologic features of lung involvement in systemic lupus erythematosus. Semin Respir Dis 1988;9:297.

  6. Nadorra RL, Landing BH. Pulmonary lesions in childhood onset systemic lupus erythematosus: analysis of 26 cases, and summary of literature. Pediatr Pathol 1987;7(1):1-18.

  7. Chantarojanasiri T, Sittirath A, Preutthipan A, Tapaneya-Olarn W, Suwanjutha S. Pulmonary involvement in childhood systemic lupus erythematosus. J Med Assoc Thai 1999;82 Suppl 1:S144-S148.

  8. Walz-Leblanc BA, Urowitz MB, Gladman DD, Hanly PJ. The “shrinking lungs syndrome” in systemic lupus erythematosus improvement with corticosteroid therapy. J Rheumatol 1992;19(12):1970-1972.

  9. Rubin LA, Urowitz MB. Shrinking lung syndrome in SLE a clinical pathologic study. J Rheumatol 1983;10(6):973-976.

  10. Winslow WA, Ploss LN, Loitman B. Pleuritis in systemic lupus erythematosus: its importance as an early manifestation in diagnosis. Ann Intern Med 1958;49(1):70-88.

  11. Alarcón-Segovia D, Alarcón DG. Pleuro-pulmonary manifestations of systemic lupus erythematosus. Dis Chest 1961;39:7-17.

  12. Caeiro F, Michielson FM, Bernstein R, Hughes GR, Ansell BM. Systemic lupus erythematosus in childhood. Ann Rheum Dis 1981;40(4):325-331.

  13. de Jongste JC, Neijens HJ, Duiverman EJ, Bogaard JM, Kerrebijn KF. Respiratory tract disease in systemic lupus erythematosus. Arch Dis Child 1986;61(5):478-483.

  14. Chandrasekhar AJ, Robinson J, Barr L. Antibody deposition in the pleura: a finding in drug-induced lupus. J Allergy Clin Immunol 1978;61(6):399-402.

  15. Khare V, Baethge B, Lang S, Wolf RE, Campbell GD Jr. Antinuclear antibodies in pleural fluid. Chest 1994;106(3):866-871.

  16. Pertschuk LP, Moccia LF, Rosen Y, et al. Acute pulmonary complications in systemic lupus erythematosus. Immunofluorescence and light microscopic study. Am J Clin Pathol 1977;68(5):553-557.

  17. Keane MP, Lynch JP 3rd. Pleuropulmonary manifestations of systemic lupus erythematosus. Thorax 2000;55(2):159-166.

  18. Brasington RD, Furst DE. Pulmonary disease in systemic lupus erythematosus. Clin Exp Rheumatol 1985;3(3):269-276.

  19. Sherer Y, Langevitz P, Levy Y, Fabrizzi F, Shoenfeld Y. Treatment of chronic bilateral pleural effusions with intravenous immunoglobulin and cyclosporin. Lupus 1999;8(4):324-327.

  20. McKnight KM, Adair NE, Agudelo CA. Successful use of tetracycline pleurodesis to treat massive pleural effusion secondary to systemic lupus erythematosus. Arthritis Rheum 1991;34(11):1483-1484.

  21. Kaine JL. Refractory massive pleural effusion in systemic lupus erythematosus treated with talc poudrage. Ann Rheum Dis 1985;44(1):61-64.

  22. Gilleece MH, Evans CC, Bucknall RC. Steroid resistant pleural effusion in systemic lupus erythematosus treated with tetracycline pleurodesis. Ann Rheum Dis 1988;47(12):1031-1032.

  23. D’Cruz D, Khamashta M, Hughes G. Pulmonary manifestations of systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois lupus erythematosus. 6th ed. Philadelphia, Lippincott: Williams and Wilkins; 2002. p. 663-684.

  24. Cardillo G, Facciolo F, Carbone L, et al. Long-term follow up of video-assisted talc pleurodesis in malignant recurrent pleural effusions. Eur J Cardiothorac Surg 2002;21(2):302-305.

  25. Saffran L, Ost DE, Fein AM, Schiff MJ. Outpatient pleurodesis of malignant pleural effusions using a small-bore pigtail catheter. Chest 2000;118(2):417-421.

  26. Anderson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer 1974;33(4):916-922.

  27. Parulekar W, Di Primio G, Matzinger F, Dennie C, Bociek G. Use of small- bore vs. large bore chest tubes for treatment of malignant pleural effusions. Chest 2001;120(1):19-25.

  28. Grossi F, Pennucci MC, Tixi L, Cafferata MA, Ardizzoni A. Management of malignant pleural effusions. Drug 1998;55(1):47-58.

  29. Petrou M, Kaplan D, Goldstraw P. Management of recurrent malignant pleural effusions. The complementary role talc pleurodesis and pleuroperitoneal shunting. Cancer 1995;75(3):801-805.

  30. Breuer GS, Deeb M, Fisher D, Nesher G. Therapeutic options for refractory massive pleural effusion in systemic lupus erythematosus: a case study and review of the literature. Semin Arthritis Rheum 2005;34(5):744-749.

  31. de Campos JR, Vargas FS, de Campos WE, et al. Thoracoscopy talc poudrage: a 15 year experience. Chest 2001;119(3):801-806.

  32. Bondoc AY, Bach PB, Sklarin NT, Vander Els NJ. Arterial desaturation syndrome following pleurodesis with talc slurry: incidence, clinical features, and outcome. Cancer Invest 2003;21(6):848-454.

  33. Rehse DH, Aye RW, Florence MG. Respiratory failure following talc pleurodesis. Am J Surg 1999;177(5):437-440.

  34. Mohsen TA, Zeid AA, Meshref M, et al. Local iodine pleurodesis versus thoracoscopic talc insufflation in recurrent malignant pleural effusion: a prospective randomized control trial. Eur J Cardthorac Surg 2011;40(2):282-286. doi: 10.1016/j.ejcts.2010.09.005.

  35. Olivares-Torres CA, Laniado-Laborín R, Chávez-García C, León-Gastelum C, Reyes-Escamilla A, Light RW. Iodopovidone pleurodesis for recurrent pleural effusions. Chest 2002;122(2):581-583.

  36. Kelly-García J, Roman-Berumen JF, Ibarra-Pérez C. Iodopovidone and bleomycin pleurodesis for effusions due to malignant epithelial neoplasms. Arch Med Res 1997;28(4):583-585.

  37. Schulze M, Boehle AS, Kurdow R, Dohrmann P, Henne-Bruns D. Effective treatment of malignant pleural effusions by minimal invasive thoracic surgery: thoracoscopic talc pleurodesis and pleuroperitoneal shunts in 101 patients. Ann Thorac Surg 2001;71(6):1809-1812.

  38. Elborn JS, Conn P, Roberts SD. Refractory massive pleural effusions in systemic lupus erythematosus treated by pleurectomy. Ann Rheum Dis 1987;46(1):77-80.

  39. Martini N, Bains MS, Beattie EJ Jr. Indications for pleurectomy in malignant effusion. Cancer 1975;35(3):734-738.

  40. Bell R, Lawrence DS. Chronic pleurisy in systemic lupus erythematosus treated with pleurectomy. Br J Dis Chest 1979;73(3):314-316.




2020     |     www.medigraphic.com